Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group
Retroperitoneal sarcomas (RPS) are heterogeneous. No previous study has investigated the impact of specialized surgery, evaluated locoregional relapse (LRR), abdominal sarcomatosis and distant metastatic relapse as separate events, or considered histological subtypes separately. This study addresses...
Gespeichert in:
Veröffentlicht in: | Annals of oncology 2014-03, Vol.25 (3), p.735-742 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 742 |
---|---|
container_issue | 3 |
container_start_page | 735 |
container_title | Annals of oncology |
container_volume | 25 |
creator | Toulmonde, M. Bonvalot, S. Méeus, P. Stoeckle, E. Riou, O. Isambert, N. Bompas, E. Jafari, M. Delcambre-Lair, C. Saada, E. Le Cesne, A. Le Péchoux, C. Blay, J.Y. Piperno-Neumann, S. Chevreau, C. Bay, J.O. Brouste, V. Terrier, P. Ranchère-Vince, D. Neuville, A. Italiano, A. |
description | Retroperitoneal sarcomas (RPS) are heterogeneous. No previous study has investigated the impact of specialized surgery, evaluated locoregional relapse (LRR), abdominal sarcomatosis and distant metastatic relapse as separate events, or considered histological subtypes separately. This study addresses these specific points in a homogeneous cohort of patients with completely resected primary RPS.
We conducted a retrospective analysis of adult patients diagnosed with a RPS between 1 January 1988 and 31 December 2008 and eventually referred to one of 12 centers of the French Sarcoma Group. All cases were centrally reviewed by an expert pathologist.
Five hundred eighty-six patients were included. Median follow-up was 6.5 years [95% confidence interval (CI) 5.9–7.1]. Five hundred thirty-seven patients had localized disease and 389 patients (76%) had macroscopically complete resection of the tumor. In this latter group, the 5-year LRR-free survival rate was 46% [41–52] and the 5-year overall survival (OS) rate was 66% [61–71]. In multivariate analysis, gender, adjacent organ involvement, specialization of the surgeon, piecemeal resection and perioperative radiotherapy were independently associated with LRR. Specialization of the surgeon and piecemeal resection were independently associated with abdominal sarcomatosis whereas histology and adjacent organ involvement were independently associated with distant metastasis. Age, gender, grade, adjacent organ involvement and piecemeal resection were significantly associated with OS. Prognostic factors for LRR and OS were analyzed in well-differentiated and dedifferentiated liposarcomas and leiomyosarcomas. Grade 3 was an independent prognostic factor for OS of dedifferentiated liposarcomas.
This study underlines the crucial role of pretherapeutic assessment and meticulous histological examination of RPS as well as the need to consider histological subtypes separately. Surgery in a specialized center and avoidance of piecemeal resection stand out as the two most important prognostic factors for RPS and highlight the importance of treating these patients in specialized centers. |
doi_str_mv | 10.1093/annonc/mdt577 |
format | Article |
fullrecord | <record><control><sourceid>elsevier_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4433510</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419342693</els_id><sourcerecordid>S0923753419342693</sourcerecordid><originalsourceid>FETCH-LOGICAL-c531t-22aab0c0d5ceac260ba83a4c0e06ba45352bbc08a0b205b0d19590e0ca021acd3</originalsourceid><addsrcrecordid>eNp1kU-L1TAUxYMoznN06VaycWedm7RpX10Iw-CMwoDgn3W4vU3fi7RJSdKB94n8mqZ0HHXhKoH7O-ce7mHspYC3AtryAp3zji6mPqmmecR2QtVtsYdKPGY7aGVZNKqsztizGH8AQN3K9ik7k5WqGyX2O_bzi0nBzybY5J3BkUcM5CeM7_iMKZngIvcDJwyGY-K9xYPz0cY3fA5-_SZLfEBKPkSOrueDpyVLHJ_QOn60MfnRHyyt1kuXTrPJ1sinZcxK4_KGLMPxlD3XRelo-HUwjo7865aE3wS_zM_ZkwHHaF7cv-fs-_WHb1cfi9vPN5-uLm8LUqVIhZSIHRD0igySrKHDfYkVgYG6w0qVSnYdwR6hk6A66EWr2jwkBCmQ-vKcvd9856WbTL8mDDjqOdgJw0l7tPrfibNHffB3uqrKUgnIBsVmQMHHGMzwoBWg18b01pjeGsv8q78XPtC_K8rA63sAY77iENCRjX-4vZS1EipzzcaZfJ47a4KOZPMhTW-DoaR7b_8T4Reyh7uC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Toulmonde, M. ; Bonvalot, S. ; Méeus, P. ; Stoeckle, E. ; Riou, O. ; Isambert, N. ; Bompas, E. ; Jafari, M. ; Delcambre-Lair, C. ; Saada, E. ; Le Cesne, A. ; Le Péchoux, C. ; Blay, J.Y. ; Piperno-Neumann, S. ; Chevreau, C. ; Bay, J.O. ; Brouste, V. ; Terrier, P. ; Ranchère-Vince, D. ; Neuville, A. ; Italiano, A.</creator><creatorcontrib>Toulmonde, M. ; Bonvalot, S. ; Méeus, P. ; Stoeckle, E. ; Riou, O. ; Isambert, N. ; Bompas, E. ; Jafari, M. ; Delcambre-Lair, C. ; Saada, E. ; Le Cesne, A. ; Le Péchoux, C. ; Blay, J.Y. ; Piperno-Neumann, S. ; Chevreau, C. ; Bay, J.O. ; Brouste, V. ; Terrier, P. ; Ranchère-Vince, D. ; Neuville, A. ; Italiano, A. ; on behalf of the French Sarcoma Group ; French Sarcoma Group</creatorcontrib><description>Retroperitoneal sarcomas (RPS) are heterogeneous. No previous study has investigated the impact of specialized surgery, evaluated locoregional relapse (LRR), abdominal sarcomatosis and distant metastatic relapse as separate events, or considered histological subtypes separately. This study addresses these specific points in a homogeneous cohort of patients with completely resected primary RPS.
We conducted a retrospective analysis of adult patients diagnosed with a RPS between 1 January 1988 and 31 December 2008 and eventually referred to one of 12 centers of the French Sarcoma Group. All cases were centrally reviewed by an expert pathologist.
Five hundred eighty-six patients were included. Median follow-up was 6.5 years [95% confidence interval (CI) 5.9–7.1]. Five hundred thirty-seven patients had localized disease and 389 patients (76%) had macroscopically complete resection of the tumor. In this latter group, the 5-year LRR-free survival rate was 46% [41–52] and the 5-year overall survival (OS) rate was 66% [61–71]. In multivariate analysis, gender, adjacent organ involvement, specialization of the surgeon, piecemeal resection and perioperative radiotherapy were independently associated with LRR. Specialization of the surgeon and piecemeal resection were independently associated with abdominal sarcomatosis whereas histology and adjacent organ involvement were independently associated with distant metastasis. Age, gender, grade, adjacent organ involvement and piecemeal resection were significantly associated with OS. Prognostic factors for LRR and OS were analyzed in well-differentiated and dedifferentiated liposarcomas and leiomyosarcomas. Grade 3 was an independent prognostic factor for OS of dedifferentiated liposarcomas.
This study underlines the crucial role of pretherapeutic assessment and meticulous histological examination of RPS as well as the need to consider histological subtypes separately. Surgery in a specialized center and avoidance of piecemeal resection stand out as the two most important prognostic factors for RPS and highlight the importance of treating these patients in specialized centers.</description><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdt577</identifier><identifier>PMID: 24567518</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Abdomen ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic agents ; Biological and medical sciences ; Dermatology ; Disease Progression ; Disease-Free Survival ; Female ; France ; Gastroenterology. Liver. Pancreas. Abdomen ; histology ; Humans ; Leiomyosarcoma - diagnosis ; Leiomyosarcoma - mortality ; Leiomyosarcoma - therapy ; Liposarcoma - diagnosis ; Liposarcoma - mortality ; Liposarcoma - therapy ; Male ; Medical sciences ; Middle Aged ; Multiple tumors. Solid tumors. Tumors in childhood (general aspects) ; Neoplasm Metastasis - pathology ; Neoplasm Metastasis - therapy ; Neoplasm Recurrence, Local ; Original ; Perioperative Care ; Pharmacology. Drug treatments ; prognosis ; Retroperitoneal Neoplasms - mortality ; Retroperitoneal Neoplasms - radiotherapy ; Retroperitoneal Neoplasms - surgery ; retroperitoneal sarcoma ; Retrospective Studies ; Sarcoma - mortality ; Sarcoma - radiotherapy ; Sarcoma - surgery ; surgery ; Survival Rate ; Treatment Outcome ; Tumors ; Tumors of the skin and soft tissue. Premalignant lesions ; Young Adult</subject><ispartof>Annals of oncology, 2014-03, Vol.25 (3), p.735-742</ispartof><rights>2014 European Society for Medical Oncology</rights><rights>2015 INIST-CNRS</rights><rights>The Author 2014. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c531t-22aab0c0d5ceac260ba83a4c0e06ba45352bbc08a0b205b0d19590e0ca021acd3</citedby><cites>FETCH-LOGICAL-c531t-22aab0c0d5ceac260ba83a4c0e06ba45352bbc08a0b205b0d19590e0ca021acd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28226515$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24567518$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Toulmonde, M.</creatorcontrib><creatorcontrib>Bonvalot, S.</creatorcontrib><creatorcontrib>Méeus, P.</creatorcontrib><creatorcontrib>Stoeckle, E.</creatorcontrib><creatorcontrib>Riou, O.</creatorcontrib><creatorcontrib>Isambert, N.</creatorcontrib><creatorcontrib>Bompas, E.</creatorcontrib><creatorcontrib>Jafari, M.</creatorcontrib><creatorcontrib>Delcambre-Lair, C.</creatorcontrib><creatorcontrib>Saada, E.</creatorcontrib><creatorcontrib>Le Cesne, A.</creatorcontrib><creatorcontrib>Le Péchoux, C.</creatorcontrib><creatorcontrib>Blay, J.Y.</creatorcontrib><creatorcontrib>Piperno-Neumann, S.</creatorcontrib><creatorcontrib>Chevreau, C.</creatorcontrib><creatorcontrib>Bay, J.O.</creatorcontrib><creatorcontrib>Brouste, V.</creatorcontrib><creatorcontrib>Terrier, P.</creatorcontrib><creatorcontrib>Ranchère-Vince, D.</creatorcontrib><creatorcontrib>Neuville, A.</creatorcontrib><creatorcontrib>Italiano, A.</creatorcontrib><creatorcontrib>on behalf of the French Sarcoma Group</creatorcontrib><creatorcontrib>French Sarcoma Group</creatorcontrib><title>Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><description>Retroperitoneal sarcomas (RPS) are heterogeneous. No previous study has investigated the impact of specialized surgery, evaluated locoregional relapse (LRR), abdominal sarcomatosis and distant metastatic relapse as separate events, or considered histological subtypes separately. This study addresses these specific points in a homogeneous cohort of patients with completely resected primary RPS.
We conducted a retrospective analysis of adult patients diagnosed with a RPS between 1 January 1988 and 31 December 2008 and eventually referred to one of 12 centers of the French Sarcoma Group. All cases were centrally reviewed by an expert pathologist.
Five hundred eighty-six patients were included. Median follow-up was 6.5 years [95% confidence interval (CI) 5.9–7.1]. Five hundred thirty-seven patients had localized disease and 389 patients (76%) had macroscopically complete resection of the tumor. In this latter group, the 5-year LRR-free survival rate was 46% [41–52] and the 5-year overall survival (OS) rate was 66% [61–71]. In multivariate analysis, gender, adjacent organ involvement, specialization of the surgeon, piecemeal resection and perioperative radiotherapy were independently associated with LRR. Specialization of the surgeon and piecemeal resection were independently associated with abdominal sarcomatosis whereas histology and adjacent organ involvement were independently associated with distant metastasis. Age, gender, grade, adjacent organ involvement and piecemeal resection were significantly associated with OS. Prognostic factors for LRR and OS were analyzed in well-differentiated and dedifferentiated liposarcomas and leiomyosarcomas. Grade 3 was an independent prognostic factor for OS of dedifferentiated liposarcomas.
This study underlines the crucial role of pretherapeutic assessment and meticulous histological examination of RPS as well as the need to consider histological subtypes separately. Surgery in a specialized center and avoidance of piecemeal resection stand out as the two most important prognostic factors for RPS and highlight the importance of treating these patients in specialized centers.</description><subject>Abdomen</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Dermatology</subject><subject>Disease Progression</subject><subject>Disease-Free Survival</subject><subject>Female</subject><subject>France</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>histology</subject><subject>Humans</subject><subject>Leiomyosarcoma - diagnosis</subject><subject>Leiomyosarcoma - mortality</subject><subject>Leiomyosarcoma - therapy</subject><subject>Liposarcoma - diagnosis</subject><subject>Liposarcoma - mortality</subject><subject>Liposarcoma - therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Multiple tumors. Solid tumors. Tumors in childhood (general aspects)</subject><subject>Neoplasm Metastasis - pathology</subject><subject>Neoplasm Metastasis - therapy</subject><subject>Neoplasm Recurrence, Local</subject><subject>Original</subject><subject>Perioperative Care</subject><subject>Pharmacology. Drug treatments</subject><subject>prognosis</subject><subject>Retroperitoneal Neoplasms - mortality</subject><subject>Retroperitoneal Neoplasms - radiotherapy</subject><subject>Retroperitoneal Neoplasms - surgery</subject><subject>retroperitoneal sarcoma</subject><subject>Retrospective Studies</subject><subject>Sarcoma - mortality</subject><subject>Sarcoma - radiotherapy</subject><subject>Sarcoma - surgery</subject><subject>surgery</subject><subject>Survival Rate</subject><subject>Treatment Outcome</subject><subject>Tumors</subject><subject>Tumors of the skin and soft tissue. Premalignant lesions</subject><subject>Young Adult</subject><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kU-L1TAUxYMoznN06VaycWedm7RpX10Iw-CMwoDgn3W4vU3fi7RJSdKB94n8mqZ0HHXhKoH7O-ce7mHspYC3AtryAp3zji6mPqmmecR2QtVtsYdKPGY7aGVZNKqsztizGH8AQN3K9ik7k5WqGyX2O_bzi0nBzybY5J3BkUcM5CeM7_iMKZngIvcDJwyGY-K9xYPz0cY3fA5-_SZLfEBKPkSOrueDpyVLHJ_QOn60MfnRHyyt1kuXTrPJ1sinZcxK4_KGLMPxlD3XRelo-HUwjo7865aE3wS_zM_ZkwHHaF7cv-fs-_WHb1cfi9vPN5-uLm8LUqVIhZSIHRD0igySrKHDfYkVgYG6w0qVSnYdwR6hk6A66EWr2jwkBCmQ-vKcvd9856WbTL8mDDjqOdgJw0l7tPrfibNHffB3uqrKUgnIBsVmQMHHGMzwoBWg18b01pjeGsv8q78XPtC_K8rA63sAY77iENCRjX-4vZS1EipzzcaZfJ47a4KOZPMhTW-DoaR7b_8T4Reyh7uC</recordid><startdate>20140301</startdate><enddate>20140301</enddate><creator>Toulmonde, M.</creator><creator>Bonvalot, S.</creator><creator>Méeus, P.</creator><creator>Stoeckle, E.</creator><creator>Riou, O.</creator><creator>Isambert, N.</creator><creator>Bompas, E.</creator><creator>Jafari, M.</creator><creator>Delcambre-Lair, C.</creator><creator>Saada, E.</creator><creator>Le Cesne, A.</creator><creator>Le Péchoux, C.</creator><creator>Blay, J.Y.</creator><creator>Piperno-Neumann, S.</creator><creator>Chevreau, C.</creator><creator>Bay, J.O.</creator><creator>Brouste, V.</creator><creator>Terrier, P.</creator><creator>Ranchère-Vince, D.</creator><creator>Neuville, A.</creator><creator>Italiano, A.</creator><general>Elsevier Ltd</general><general>Oxford University Press</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20140301</creationdate><title>Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group</title><author>Toulmonde, M. ; Bonvalot, S. ; Méeus, P. ; Stoeckle, E. ; Riou, O. ; Isambert, N. ; Bompas, E. ; Jafari, M. ; Delcambre-Lair, C. ; Saada, E. ; Le Cesne, A. ; Le Péchoux, C. ; Blay, J.Y. ; Piperno-Neumann, S. ; Chevreau, C. ; Bay, J.O. ; Brouste, V. ; Terrier, P. ; Ranchère-Vince, D. ; Neuville, A. ; Italiano, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c531t-22aab0c0d5ceac260ba83a4c0e06ba45352bbc08a0b205b0d19590e0ca021acd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Abdomen</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Dermatology</topic><topic>Disease Progression</topic><topic>Disease-Free Survival</topic><topic>Female</topic><topic>France</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>histology</topic><topic>Humans</topic><topic>Leiomyosarcoma - diagnosis</topic><topic>Leiomyosarcoma - mortality</topic><topic>Leiomyosarcoma - therapy</topic><topic>Liposarcoma - diagnosis</topic><topic>Liposarcoma - mortality</topic><topic>Liposarcoma - therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Multiple tumors. Solid tumors. Tumors in childhood (general aspects)</topic><topic>Neoplasm Metastasis - pathology</topic><topic>Neoplasm Metastasis - therapy</topic><topic>Neoplasm Recurrence, Local</topic><topic>Original</topic><topic>Perioperative Care</topic><topic>Pharmacology. Drug treatments</topic><topic>prognosis</topic><topic>Retroperitoneal Neoplasms - mortality</topic><topic>Retroperitoneal Neoplasms - radiotherapy</topic><topic>Retroperitoneal Neoplasms - surgery</topic><topic>retroperitoneal sarcoma</topic><topic>Retrospective Studies</topic><topic>Sarcoma - mortality</topic><topic>Sarcoma - radiotherapy</topic><topic>Sarcoma - surgery</topic><topic>surgery</topic><topic>Survival Rate</topic><topic>Treatment Outcome</topic><topic>Tumors</topic><topic>Tumors of the skin and soft tissue. Premalignant lesions</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Toulmonde, M.</creatorcontrib><creatorcontrib>Bonvalot, S.</creatorcontrib><creatorcontrib>Méeus, P.</creatorcontrib><creatorcontrib>Stoeckle, E.</creatorcontrib><creatorcontrib>Riou, O.</creatorcontrib><creatorcontrib>Isambert, N.</creatorcontrib><creatorcontrib>Bompas, E.</creatorcontrib><creatorcontrib>Jafari, M.</creatorcontrib><creatorcontrib>Delcambre-Lair, C.</creatorcontrib><creatorcontrib>Saada, E.</creatorcontrib><creatorcontrib>Le Cesne, A.</creatorcontrib><creatorcontrib>Le Péchoux, C.</creatorcontrib><creatorcontrib>Blay, J.Y.</creatorcontrib><creatorcontrib>Piperno-Neumann, S.</creatorcontrib><creatorcontrib>Chevreau, C.</creatorcontrib><creatorcontrib>Bay, J.O.</creatorcontrib><creatorcontrib>Brouste, V.</creatorcontrib><creatorcontrib>Terrier, P.</creatorcontrib><creatorcontrib>Ranchère-Vince, D.</creatorcontrib><creatorcontrib>Neuville, A.</creatorcontrib><creatorcontrib>Italiano, A.</creatorcontrib><creatorcontrib>on behalf of the French Sarcoma Group</creatorcontrib><creatorcontrib>French Sarcoma Group</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Toulmonde, M.</au><au>Bonvalot, S.</au><au>Méeus, P.</au><au>Stoeckle, E.</au><au>Riou, O.</au><au>Isambert, N.</au><au>Bompas, E.</au><au>Jafari, M.</au><au>Delcambre-Lair, C.</au><au>Saada, E.</au><au>Le Cesne, A.</au><au>Le Péchoux, C.</au><au>Blay, J.Y.</au><au>Piperno-Neumann, S.</au><au>Chevreau, C.</au><au>Bay, J.O.</au><au>Brouste, V.</au><au>Terrier, P.</au><au>Ranchère-Vince, D.</au><au>Neuville, A.</au><au>Italiano, A.</au><aucorp>on behalf of the French Sarcoma Group</aucorp><aucorp>French Sarcoma Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2014-03-01</date><risdate>2014</risdate><volume>25</volume><issue>3</issue><spage>735</spage><epage>742</epage><pages>735-742</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><abstract>Retroperitoneal sarcomas (RPS) are heterogeneous. No previous study has investigated the impact of specialized surgery, evaluated locoregional relapse (LRR), abdominal sarcomatosis and distant metastatic relapse as separate events, or considered histological subtypes separately. This study addresses these specific points in a homogeneous cohort of patients with completely resected primary RPS.
We conducted a retrospective analysis of adult patients diagnosed with a RPS between 1 January 1988 and 31 December 2008 and eventually referred to one of 12 centers of the French Sarcoma Group. All cases were centrally reviewed by an expert pathologist.
Five hundred eighty-six patients were included. Median follow-up was 6.5 years [95% confidence interval (CI) 5.9–7.1]. Five hundred thirty-seven patients had localized disease and 389 patients (76%) had macroscopically complete resection of the tumor. In this latter group, the 5-year LRR-free survival rate was 46% [41–52] and the 5-year overall survival (OS) rate was 66% [61–71]. In multivariate analysis, gender, adjacent organ involvement, specialization of the surgeon, piecemeal resection and perioperative radiotherapy were independently associated with LRR. Specialization of the surgeon and piecemeal resection were independently associated with abdominal sarcomatosis whereas histology and adjacent organ involvement were independently associated with distant metastasis. Age, gender, grade, adjacent organ involvement and piecemeal resection were significantly associated with OS. Prognostic factors for LRR and OS were analyzed in well-differentiated and dedifferentiated liposarcomas and leiomyosarcomas. Grade 3 was an independent prognostic factor for OS of dedifferentiated liposarcomas.
This study underlines the crucial role of pretherapeutic assessment and meticulous histological examination of RPS as well as the need to consider histological subtypes separately. Surgery in a specialized center and avoidance of piecemeal resection stand out as the two most important prognostic factors for RPS and highlight the importance of treating these patients in specialized centers.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>24567518</pmid><doi>10.1093/annonc/mdt577</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0923-7534 |
ispartof | Annals of oncology, 2014-03, Vol.25 (3), p.735-742 |
issn | 0923-7534 1569-8041 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4433510 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Abdomen Adolescent Adult Aged Aged, 80 and over Antineoplastic agents Biological and medical sciences Dermatology Disease Progression Disease-Free Survival Female France Gastroenterology. Liver. Pancreas. Abdomen histology Humans Leiomyosarcoma - diagnosis Leiomyosarcoma - mortality Leiomyosarcoma - therapy Liposarcoma - diagnosis Liposarcoma - mortality Liposarcoma - therapy Male Medical sciences Middle Aged Multiple tumors. Solid tumors. Tumors in childhood (general aspects) Neoplasm Metastasis - pathology Neoplasm Metastasis - therapy Neoplasm Recurrence, Local Original Perioperative Care Pharmacology. Drug treatments prognosis Retroperitoneal Neoplasms - mortality Retroperitoneal Neoplasms - radiotherapy Retroperitoneal Neoplasms - surgery retroperitoneal sarcoma Retrospective Studies Sarcoma - mortality Sarcoma - radiotherapy Sarcoma - surgery surgery Survival Rate Treatment Outcome Tumors Tumors of the skin and soft tissue. Premalignant lesions Young Adult |
title | Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T23%3A04%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Retroperitoneal%20sarcomas:%20patterns%20of%20care%20at%20diagnosis,%20prognostic%20factors%20and%20focus%20on%20main%20histological%20subtypes:%20a%20multicenter%20analysis%20of%20the%20French%20Sarcoma%20Group&rft.jtitle=Annals%20of%20oncology&rft.au=Toulmonde,%20M.&rft.aucorp=on%20behalf%20of%20the%20French%20Sarcoma%20Group&rft.date=2014-03-01&rft.volume=25&rft.issue=3&rft.spage=735&rft.epage=742&rft.pages=735-742&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdt577&rft_dat=%3Celsevier_pubme%3ES0923753419342693%3C/elsevier_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/24567518&rft_els_id=S0923753419342693&rfr_iscdi=true |